Xue Chen

Dr. Xue Chen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
SJSiyuan Jia
Siyuan Jia
ABAnn M. Bode
Ann M. Bode
XCXue Chen
Xue Chen
XLXiangjian Luo
Xiangjian Luo

16 November 2023 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
QLQian Liu
Qian Liu
ABAnn M. Bode
Ann M. Bode
XCXue Chen
Xue Chen
XLXiangjian Luo
Xiangjian Luo

24 June 2025 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
QLQian Liu
Qian Liu
HLHan Li
Han Li
XCXue Chen
Xue Chen
XLXiangjian Luo
Xiangjian Luo

1 December 2021 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
XCXue Chen
Xue Chen
FYFeng Yang
Feng Yang
JZJiao Zhao
Jiao Zhao
QTQi Tang
Qi Tang
JHJianfu Heng
Jianfu Heng
JWJing Wang
Jing Wang


15 September 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SZShuzhao Zhang
Shuzhao Zhang
JQJing Quan
Jing Quan
NLNamei Li
Namei Li
GHGuangxian Hu
Guangxian Hu
XLXiangjian Luo
Xiangjian Luo
XCXue Chen
Xue Chen
The circadian rhythm is a fundamental biological phenomenon regulated by the clock gene family. Disruption of clock genes has been linked to various diseases, including cancer. Cryptochrome 2 (CRY2), a core circadian component, plays a role in tumorigenesis, yet its function in nasopharyngeal carcinoma (NPC) remains unclear. Epstein-Barr virus (EBV) infection is a key oncogenic factor in NPC, with latent membrane protein 1 (LMP1) being one of EBV-encoded principal oncoproteins. In the present study, we demonstrate that CRY2 mediates LMP1-induced proliferation, immune escape, and chemoresistance in NPC cells. Mechanistically, LMP1 enhances CRY2 stability by regulating phosphorylation-ubiquitination cascades and disrupting CRY2-FBXL3 interactions. CRY2 activates STAT3 to upregulate PD-L1, suppressing T-cell antitumor activity. Our findings elucidate the molecular link between EBV and circadian clock genes and identify the EBV-LMP1/CRY2 axis as a novel oncogenic pathway in NPC progression, highlighting CRY2 as a potential therapeutic target in EBV-associated cancers.